Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.
äŒæ¥ã³ãŒãVTAK
äŒç€ŸåCatheter Precision Inc
äžå Žæ¥Sep 27, 2018
æé«çµå¶è²¬ä»»è
ãCEOãJenkins (David A)
åŸæ¥å¡æ°22
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Sep 27
æ¬ç€Ÿæåšå°1670 Highway 160 West
éœåžFORT MILL
蚌åžååŒæNASDAQ OMX â NASDAQ Basic Amex
åœUnited States of America
éµäŸ¿çªå·29708
é»è©±çªå·19736912000
ãŠã§ããµã€ãhttps://www.ramed.com/
äŒæ¥ã³ãŒãVTAK
äžå Žæ¥Sep 27, 2018
æé«çµå¶è²¬ä»»è
ãCEOãJenkins (David A)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã